Measuring hypoxia in solid tumours--is there a gold standard?

Tumour hypoxia is known to be associated with aggressiveness and poor response to treatment, which has stimulated the development of several methods able to detect hypoxic tumours. To date, only one method, the oxygen microelectrode, has been used to provide pretreatment measures of tumour oxygenation that correlate with local control and disease-free survival. In an effort to validate new methods, comparisons have been made between the Eppendorf oxygen microelectrode, the comet assay, and hypoxia marker binding in tumours of patients undergoing curative treatment or palliative radiotherapy. These comparisons suggest that tumours with median oxygen tensions below 10 mmHg have relatively high hypoxic fractions as measured by the comet assay (> 0.20). The fraction of cells that binds pimonidazole, detected in cells obtained by fine-needle aspiration biopsy, correlates well with the hypoxic fraction measured using the comet assay. However, in general, hypoxic fractions measured by the comet assay and pimonidazole binding correlate only poorly with Eppendorf measurements performed for the same tumour. Factors that might be responsible for these differences, and problems associated with measuring the 'relevant' hypoxic population are discussed.

[1]  M. Varia,et al.  A clinical study of hypoxia and metallothionein protein expression in squamous cell carcinomas. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[2]  D. Chaplin,et al.  Intermittent blood flow in a murine tumor: radiobiological effects. , 1987, Cancer research.

[3]  C. Grau,et al.  Relationship between radiobiological hypoxia in tumors and electrode measurements of tumor oxygenation. , 1994, International journal of radiation oncology, biology, physics.

[4]  R. Jain,et al.  Role of tumor vascular architecture in nutrient and drug delivery: an invasion percolation-based network model. , 1996, Microvascular research.

[5]  Y. D'Asseler,et al.  99Tcm labelled HL91 versus computed tomography and biopsy for the visualization of tumour recurrence of squamous head and neck carcinoma , 2001 .

[6]  A. Waites,et al.  Vasculature and microenvironmental gradients: the missing links in novel approaches to cancer therapy? , 1998, Advances in enzyme regulation.

[7]  R. Airley,et al.  Glucose transporter glut-1 expression correlates with tumor hypoxia and predicts metastasis-free survival in advanced carcinoma of the cervix. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

[8]  R E Durand,et al.  Heterogeneity in radiation-induced DNA damage and repair in tumor and normal cells measured using the "comet" assay. , 1990, Radiation research.

[9]  P. Olive,et al.  Overnight Lysis Improves the Efficiency of Detection of DNA Damage in the Alkaline Comet Assay , 2001, Radiation research.

[10]  R E Durand,et al.  Detection of hypoxic cells in a murine tumor with the use of the comet assay. , 1992, Journal of the National Cancer Institute.

[11]  E. Glatstein,et al.  Seduced by oxygen. , 1988, International journal of radiation oncology, biology, physics.

[12]  J P Logue,et al.  Tumour oxygenation levels correlate with dynamic contrast-enhanced magnetic resonance imaging parameters in carcinoma of the cervix. , 2000, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[13]  J. Denekamp,et al.  Inducible repair and the two forms of tumour hypoxia--time for a paradigm shift. , 1999, Acta oncologica.

[14]  R. Bristow,et al.  The p53 gene as a modifier of intrinsic radiosensitivity: implications for radiotherapy. , 1996, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[15]  Janice M. Y. Brown,et al.  The hypoxic cell: a target for selective cancer therapy--eighteenth Bruce F. Cain Memorial Award lecture. , 1999, Cancer research.

[16]  C. Grau,et al.  Detection of hypoxic cells in a C3H mouse mammary carcinoma using the comet assay. , 1997, British Journal of Cancer.

[17]  J. Overgaard,et al.  Pretreatment oxygenation predicts radiation response in advanced squamous cell carcinoma of the head and neck. , 1996, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[18]  T. Pickles,et al.  Impact of nicotinamide on human tumour hypoxic fraction measured using the comet assay. , 1997, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[19]  Raleigh,et al.  Measuring Tumor Hypoxia. , 1996, Seminars in radiation oncology.

[20]  J. Horiot,et al.  ARCON: accelerated radiotherapy with carbogen and nicotinamide in head and neck squamous cell carcinomas. The experience of the Co-operative group of radiotherapy of the european organization for research and treatment of cancer (EORTC). , 2000, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[21]  David E. Housman,et al.  Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours , 1996, Nature.

[22]  D. Hedley,et al.  A comparison in individual murine tumors of techniques for measuring oxygen levels. , 1999, International journal of radiation oncology, biology, physics.

[23]  A. Giaccia,et al.  Hypoxic Stress Proteins: Survival of the Fittest. , 1996, Seminars in radiation oncology.

[24]  R J Hodgkiss,et al.  Spatial relationship between hypoxia and the (perfused) vascular network in a human glioma xenograft: a quantitative multi-parameter analysis. , 2000, International journal of radiation oncology, biology, physics.

[25]  G. Semenza,et al.  Hypoxia, Clonal Selection, and the Role of HIF-1 in Tumor Progression , 2000, Critical reviews in biochemistry and molecular biology.

[26]  P Vaupel,et al.  Intratumoral pO2 predicts survival in advanced cancer of the uterine cervix. , 1993, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[27]  P. Olive,et al.  DNA damage and repair in individual cells: applications of the comet assay in radiobiology. , 1999, International journal of radiation biology.

[28]  W. Sly,et al.  Expression of hypoxia-inducible cell-surface transmembrane carbonic anhydrases in human cancer. , 2001, The American journal of pathology.

[29]  B. Wouters,et al.  Cells at intermediate oxygen levels can be more important than the "hypoxic fraction" in determining tumor response to fractionated radiotherapy. , 1997, Radiation research.

[30]  P H Watson,et al.  Hypoxia-inducible expression of tumor-associated carbonic anhydrases. , 2000, Cancer research.

[31]  T L Phillips,et al.  Oxygen in human tumors: correlations between methods of measurement and response to therapy. Summary of a workshop held November 19-20, 1992, at the National Cancer Institute, Bethesda, Maryland. , 1993, Radiation research.

[32]  E. Rogakou,et al.  DNA Double-stranded Breaks Induce Histone H2AX Phosphorylation on Serine 139* , 1998, The Journal of Biological Chemistry.

[33]  C. Aquino-Parsons,et al.  A pilot study comparing intratumoral oxygenation using the comet assay following 2.5% and 5% carbogen and 100% oxygen. , 2001, International journal of radiation oncology, biology, physics.

[34]  P. Olive,et al.  RPA Foci are Associated with Cell Death after Irradiation , 2001, Radiation research.

[35]  R. Kerbel,et al.  Oncogenes and angiogenesis: signaling three-dimensional tumor growth. , 2000, The journal of investigative dermatology. Symposium proceedings.

[36]  J. Overgaard,et al.  Invasive oxygen measurements and pimonidazole labeling in human cervix carcinoma. , 2001, International journal of radiation oncology, biology, physics.

[37]  C. Aquino-Parsons,et al.  Comparison between the comet assay and pimonidazole binding for measuring tumour hypoxia , 2000, British Journal of Cancer.

[38]  J. Overgaard Clinical evaluation of nitroimidazoles as modifiers of hypoxia in solid tumors. , 1994, Oncology research.

[39]  C. Aquino-Parsons,et al.  Oxygen tension in primary gynaecological tumours: the influence of carbon dioxide concentration. , 2000, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[40]  C. Aquino-Parsons,et al.  Comparison between the comet assay and the oxygen microelectrode for measurement of tumor hypoxia. , 1999, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[41]  A. Fyles,et al.  Oxygenation predicts radiation response and survival in patients with cervix cancer. , 1998, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[42]  G M Tozer,et al.  Hypoxia modulated gene expression: angiogenesis, metastasis and therapeutic exploitation. , 2000, European journal of cancer.

[43]  M. Dewhirst,et al.  Fluctuations in red cell flux in tumor microvessels can lead to transient hypoxia and reoxygenation in tumor parenchyma. , 1996, Cancer research.

[44]  M. Dewhirst,et al.  Tumor hypoxia adversely affects the prognosis of carcinoma of the head and neck. , 1997, International journal of radiation oncology, biology, physics.

[45]  E. Rofstad Microenvironment-induced cancer metastasis , 2000, International journal of radiation biology.

[46]  J. Fowler,et al.  Pre-therapeutic experiments with the fast neutron beam from the Medical Research Council cyclotron. I. The biological and physical advantages and problems of neutron therapy. , 1963, The British journal of radiology.